查找与器官及解剖学疾病相关的、专注于疾病的小分子,用于转化研究、模型选择及药物发现工作流程。利用本页面浏览按组织特异性或系统级疾病生物学分类的化合物。
器官/解剖疾病
按类别选购
神经系统疾病(DOID:863) nervous system disease (DOID:863)
1,388胃肠道系统疾病(DOID:77) gastrointestinal system disease (DOID:77)
3,892心血管系统疾病(DOID:1287) cardiovascular system disease (DOID:1287)
2,720免疫系统疾病(DOID:2914) immune system disease (DOID:2914)
986肌肉骨骼系统疾病(DOID:17) musculoskeletal system disease (DOID:17)
759内分泌系统疾病(DOID:28) endocrine system disease (DOID:28)
3,795泌尿系统疾病(DOID:18) urinary system disease (DOID:18)
123呼吸系统疾病(DOID:1579) respiratory system disease (DOID:1579)
4,223生殖系统疾病(DOID:15) reproductive system disease (DOID:15)
373胸外科疾病(DOID:0060118) thoracic disease (DOID:0060118)
1,268皮肤系统疾病(DOID:16) integumentary system disease (DOID:16)
1,919造血系统疾病(DOID:74) hematopoietic system disease (DOID:74)
725产品列表
-
(3R)-8-Fluoro-1-methyl-3-[2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-2,4(1H,3H)-quinazolinedione期货 货号: F630119查看产品价格与包装
技术标识符
- IUPAC名称
- 8-fluoro-1-methyl-3-[2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]quinazoline-2,4-dione
- SMILES
- B1(OC(C(O1)(C)C)(C)C)C2=C(C(=CC=C2)N3C(=O)C4=C(C(=CC=C4)F)N(C3=O)C)C
- InChIKey
- IOWQECWLWYVSTB-UHFFFAOYSA-N
- InChI
- 1S/C22H24BFN2O4/c1-13-15(23-29-21(2,3)22(4,5)30-23)10-8-12-17(13)26-19(27)14-9-7-11-16(24)18(14)25(6)20(26)28/h7-12H,1-6H3
-
(3S)-8-Fluoro-1-methyl-3-[2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-2,4(1H,3H)-quinazolinedione期货 货号: F630118查看产品价格与包装
技术标识符
- IUPAC名称
- 8-fluoro-1-methyl-3-[2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]quinazoline-2,4-dione
- SMILES
- B1(OC(C(O1)(C)C)(C)C)C2=C(C(=CC=C2)N3C(=O)C4=C(C(=CC=C4)F)N(C3=O)C)C
- InChIKey
- IOWQECWLWYVSTB-UHFFFAOYSA-N
- InChI
- 1S/C22H24BFN2O4/c1-13-15(23-29-21(2,3)22(4,5)30-23)10-8-12-17(13)26-19(27)14-9-7-11-16(24)18(14)25(6)20(26)28/h7-12H,1-6H3
-
2-乙基-5,7-二甲基-1H-咪唑并[4,5-b]吡啶有现货 货号: E635555查看产品价格与包装
技术标识符
- IUPAC名称
- 2-ethyl-5,7-dimethyl-1H-imidazo[4,5-b]pyridine
- SMILES
- CCC1=NC2=C(N1)C(=CC(=N2)C)C
- InChIKey
- XWWJWZJOSWSJQV-UHFFFAOYSA-N
- InChI
- 1S/C10H13N3/c1-4-8-12-9-6(2)5-7(3)11-10(9)13-8/h5H,4H2,1-3H3,(H,11,12,13)
-
3-[(2S)-6-[(E)-2-[2-chloro-6-(trifluoromethyl)phenyl]vinyl]-4-[3-(trifluoromethyl)phenyl]sulfonyl-2,3-dihydro-1,4-benzoxazin-2-yl]propanoic acid期货 货号: V630618查看产品价格与包装
技术标识符
- IUPAC名称
- 3-[(2S)-6-[(E)-2-[2-chloro-6-(trifluoromethyl)phenyl]ethenyl]-4-[3-(trifluoromethyl)phenyl]sulfonyl-2,3-dihydro-1,4-benzoxazin-2-yl]propanoic acid
- SMILES
- C1C(OC2=C(N1S(=O)(=O)C3=CC=CC(=C3)C(F)(F)F)C=C(C=C2)C=CC4=C(C=CC=C4Cl)C(F)(F)F)CCC(=O)O
- InChIKey
- HNQAJIBKSKZNTO-HKMNZKMDSA-N
- InChI
- 显示更多
-
3-[2,4-bis[(3S)-3-methylmorpholin-4-yl]pyrido[2,3-d]pyrimidin-7-yl]benzoic acid期货 货号: P626508查看产品价格与包装
技术标识符
- IUPAC名称
- 3-[2,4-bis[(3S)-3-methylmorpholin-4-yl]pyrido[2,3-d]pyrimidin-7-yl]benzoic acid
- SMILES
- CC1COCCN1C2=NC(=NC3=C2C=CC(=N3)C4=CC(=CC=C4)C(=O)O)N5CCOCC5C
- InChIKey
- NGXAJVNTIQZDCB-HOTGVXAUSA-N
- InChI
- 1S/C24H27N5O4/c1-15-13-32-10-8-28(15)22-19-6-7-20(17-4-3-5-18(12-17)23(30)31)25-21(19)26-24(27-22)29-9-11-33-14-16(29)2/h3-7,12,15-16H,8-11,13-14H2,1-2H3,(H,30,31)/t15-,16-/m0/s1
-
8-fluoro-1-methyl-3-[2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]quinazoline-2,4-dione期货 货号: F630112查看产品价格与包装
技术标识符
- IUPAC名称
- 8-fluoro-1-methyl-3-[2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]quinazoline-2,4-dione
- SMILES
- B1(OC(C(O1)(C)C)(C)C)C2=C(C(=CC=C2)N3C(=O)C4=C(C(=CC=C4)F)N(C3=O)C)C
- InChIKey
- IOWQECWLWYVSTB-UHFFFAOYSA-N
- InChI
- 1S/C22H24BFN2O4/c1-13-15(23-29-21(2,3)22(4,5)30-23)10-8-12-17(13)26-19(27)14-9-7-11-16(24)18(14)25(6)20(26)28/h7-12H,1-6H3
-
N,N-二甲基甲酰胺 (DMF)有现货 货号: D639253查看产品价格与包装
技术标识符
- IUPAC名称
- N,N-dimethylformamide
- SMILES
- CN(C)C=O
- InChIKey
- ZMXDDKWLCZADIW-UHFFFAOYSA-N
- InChI
- 1S/C3H7NO/c1-4(2)3-5/h3H,1-2H3
-
vapiprostCAS: 85505-64-2 化合物 CID: 6918030Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: V614711查看产品价格与包装
技术标识符
- IUPAC名称
- (Z)-7-[(1R,2R,3S,5S)-3-hydroxy-5-[(4-phenylphenyl)methoxy]-2-piperidin-1-ylcyclopentyl]hept-4-enoic acid
- SMILES
- C1CCN(CC1)C2C(CC(C2CCC=CCCC(=O)O)OCC3=CC=C(C=C3)C4=CC=CC=C4)O
- InChIKey
- GQGRDYWMOPRROR-XUSMOFMBSA-N
- InChI
- 显示更多
-
PD-156707Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: P612655查看产品价格与包装
技术标识符
- IUPAC名称
- sodium;(Z)-2-(1,3-benzodioxol-5-yl)-4-(4-methoxyphenyl)-4-oxo-3-[(3,4,5-trimethoxyphenyl)methyl]but-2-enoate
- SMILES
- COC1=CC=C(C=C1)C(=O)C(=C(C2=CC3=C(C=C2)OCO3)C(=O)[O-])CC4=CC(=C(C(=C4)OC)OC)OC.[Na+]
- InChIKey
- ZLHQEGFYBMZQGM-RKVLWQGQSA-M
- InChI
- 1S/C28H26O9.Na/c1-32-19-8-5-17(6-9-19)26(29)20(11-16-12-23(33-2)27(35-4)24(13-16)34-3)25(28(30)31)18-7-10-21-22(14-18)37-15-36-21;/h5-10,12-14H,11,15H2,1-4H3,(H,30,31);/q;+1/p-1/b25-20-;
-
RO5101576CAS: 1123155-95-2 化合物 CID: 25192022Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: R613251查看产品价格与包装
技术标识符
- IUPAC名称
- 4-(3-{6-[3-(2H-1,3-benzodioxol-5-yl)-5-(thiophen-3-yl)phenoxy]hexyl}-2-(2-carboxyethyl)phenoxy)butanoic acid
- SMILES
- OC(=O)CCc1c(CCCCCCOc2cc(cc(c2)c2ccc3c(c2)OCO3)c2ccsc2)cccc1OCCCC(=O)O
- InChIKey
- SRPFDFNVILUDAI-UHFFFAOYSA-N
- InChI
- 显示更多
-
PU-H71 XHBrCAS: 873436-91-0(free) 分子式: C18H21IN6O2S XHBr 分子量: 512.37(free)有现货 货号: P639831查看产品价格与包装
技术标识符
- IUPAC名称
- 8-[(6-iodo-1,3-benzodioxol-5-yl)sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine
- SMILES
- CC(C)NCCCN1C2=NC=NC(=C2N=C1SC3=C(C=C4C(=C3)OCO4)I)N
- InChIKey
- SUPVGFZUWFMATN-UHFFFAOYSA-N
- InChI
- 1S/C18H21IN6O2S/c1-10(2)21-4-3-5-25-17-15(16(20)22-8-23-17)24-18(25)28-14-7-13-12(6-11(14)19)26-9-27-13/h6-8,10,21H,3-5,9H2,1-2H3,(H2,20,22,23)
快速发货
现货产品当日发货
技术详情
每个产品页均提供质量和规格信息
多种规格
多种包装规格和价格可选
仅供科研
产品仅供研发使用
常见问题
最后更新:2026年11月5日
器官/解剖疾病下收录了哪些内容?
该分类汇集了注释到与器官/解剖疾病相关靶点和通路的化合物及工具分子。它是快速圈定研究用化合物集的入口,不构成任何治疗建议。
器官/解剖疾病涵盖哪些内容?
器官/解剖疾病是按疾病分类(DOID)下按疾病注释的分类,汇集了跨多个靶点家族、在该领域有相关报道的化合物。
如何为器官/解剖疾病研究挑选化合物?
针对器官/解剖疾病,建议从靶点或通路假设出发,而非从疾病标签出发,随后核实所报道的活性是否在与您体系相关的模型中测得。在确定化合物集之前,请确认效价、选择性和溶解性。所有产品仅供专业研发用途,不得用于人体、动物、诊断或治疗。
如何在器官/解剖疾病下查找特定化合物?
可在器官/解剖疾病中按化合物名称、CAS号或SMILES搜索,也可按对应靶点筛选。未收录的化合物或大包装请联系 compliance@aladdinsci.com。我们仅向经核实的企业、科研机构、高校和政府机构供货。
![(3R)-8-Fluoro-1-methyl-3-[2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-2,4(1H,3H)-quinazolinedione](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/F/6/F630119.png)
![(3S)-8-Fluoro-1-methyl-3-[2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-2,4(1H,3H)-quinazolinedione](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/F/6/F630118.png)
![2-乙基-5,7-二甲基-1H-咪唑并[4,5-b]吡啶](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/E/6/E635555.png)
![3-[(2S)-6-[(E)-2-[2-chloro-6-(trifluoromethyl)phenyl]vinyl]-4-[3-(trifluoromethyl)phenyl]sulfonyl-2,3-dihydro-1,4-benzoxazin-2-yl]propanoic acid](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/V/6/V630618.png)
![3-[2,4-bis[(3S)-3-methylmorpholin-4-yl]pyrido[2,3-d]pyrimidin-7-yl]benzoic acid](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/P/6/P626508.png)
![8-fluoro-1-methyl-3-[2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]quinazoline-2,4-dione](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/F/6/F630112.png)






危险品化学品经营许可证(带存储)